Arbor Rapha Capital Bioholdings Corp. I Warrants
ARCKW
ARCKW was delisted on the 10th of January, 2023.
14 hedge funds and large institutions have $1.88M invested in Arbor Rapha Capital Bioholdings Corp. I Warrants in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$197K |
| 2 |
FTCM
Fir Tree Capital Management
New York
|
+$60.8K |
| 3 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$52.1K |
| 4 |
D.E. Shaw & Co
New York
|
+$46.3K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$34.7K |
Top Sellers
ARCKW Hedge Fund Activity: Q4 2021 in Review
14 of the 6,519 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Warrants (ARCKW) for Q4 2021, worth a combined $1.88M.
Buyers outnumbered sellers: 14 funds opened new ARCKW positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $197K.
- 14 institutional investors held Arbor Rapha Capital Bioholdings Corp. I Warrants (ARCKW) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $1.88M of Arbor Rapha Capital Bioholdings Corp. I Warrants stock for Q4 2021.
- 14 funds opened new Arbor Rapha Capital Bioholdings Corp. I Warrants positions in Q4 2021 and 0 closed out, a net change of +14 holders.
- The largest Arbor Rapha Capital Bioholdings Corp. I Warrants buyer in Q4 2021 was Saba Capital Management, an estimated $197K added.
Based on aggregated 13F filings for Q4 2021.